Director
DIN: 09505839
Rohit Ramprasad Kewat is currently associated with 3 companies in various capacities such as Designated Partner, Director and Non- Individual Subscriber. They serve as a Director at BAXAY HEALTHCARE LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09505839.Rohit Ramprasad Kewat is currently involved in 3 different roles. Their most recent position is with PTOLEMY PHARMACEUTICALS PRIVATE LIMITED as a Non- Individual Subscriber. The first company Rohit Ramprasad Kewat was appointed to as a director was BAXAY HEALTHCARE LLP. Rohit Ramprasad Kewat is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Rohit Ramprasad Kewat is currently associated with 3 companies in various capacities such as Designated Partner, Director and Non- Individual Subscriber. They serve as a Director at BAXAY HEALTHCARE LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09505839.Rohit Ramprasad Kewat is currently involved in 3 different roles. Their most recent position is with PTOLEMY PHARMACEUTICALS PRIVATE LIMITED as a Non- Individual Subscriber. The first company Rohit Ramprasad Kewat was appointed to as a director was BAXAY HEALTHCARE LLP. Rohit Ramprasad Kewat is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (1)
Past Companies (0)
11 Months 6 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ROKE MEDIVENTURES PRIVATE LIMITED | Director | 29-Dec-2023 |
| PTOLEMY PHARMACEUTICALS PRIVATE LIMITED | Non- Individual Subscriber | 27-May-2024 |
| PTOLEMY PHARMACEUTICALS PRIVATE LIMITED | Director | 27-May-2024 |